MARANDA GARY: Open Payments
NPI 1033547658 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 17 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 3 | $94 |
| PFIZER INC. | 2 | $52 |
| Janssen Biotech, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $32 |
| SK Life Science, Inc. | 1 | $29 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Neurelis, Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Impel Pharmaceuticals LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: Zilbrysq, NURTEC ODT, Fintepla, HYQVIA, INBRIJA, VALTOCO, AUSTEDO XR, TRUDHESA.
Industry payments across FL — which companies pay providers there.
